PetLife Pharmaceuticals and Lumleian, LLC Announce Partnership to Advance Development and Commercialization of Promising Veterinary Health Pipeline

Hancock, MD, Oct. 27, 2016, PTLF, (GLOBE NEWSWIRE) Hancock, MD Innovative veterinary health company, PetLife Pharmaceuticals, Inc. (OTC QB: PTLF), announced today a partnership with Lumleian, LLC, a life sciences advisory firm based in Boston, MA. Working together, PetLife and Lumleian will seek to advance PetLife s clinical and commercial pipeline in the United States, including securing capital to develop its lead product, Vitalzul™, for the treatment of various veterinary oncology indications. Dr. Salvagno, CEO of PetLife Pharmaceuticals, noted,
http://bit.ly/2fjD9iW